2nd European Training Course on PK-PD of Protein Therapeutics, Darmstadt, August 29-31 2017: Late-bird registration!

2017-08-01 15:11 GMT+02:00 Emilie Henin <emilie.henin_at_gmail.com>: > Dear Colleagues, > > > > Few seats are still available for the > > *2nd European Training Course on Pharmacokinetics and Pharmacodynamics of > Protein Therapeutics – Principles and Pharmacometric Approaches* > > > > Directed by Bernd Meibohm (University of Tennessee) and Johan Gabrielsson > (Swedish University of Agricultural Sciences ) > > To be held in Darmstadt, Germany on *August 29-31, 2017*. > > > > Thanks to the sponsoring of Merck, seats for academics and students are > available at a reduced fee (500€ instead of 1400€, includ ing fees for > course, lunches and coffee breaks) > > > > > > For more information, please contact us at contact_at_ap2pop.org or click on > the links below > > > > *Information:* * http://www.ap2pop.org/formations > http://www.ap2pop.org/formations* > > *Registration form:* http://www.ap2pop.org/assets/PDF/Plaquette- > formation-AP2POP-2017-PKPDofPT.pdf > > > > > > On behalf of the organising committee, > > > > > > *Emilie HENIN, PhD HDR* > > Consultant in Pharmacometrics > > > > AP2POP, Association pour la Promotion de la Pharmacocinétique de Pop ulation > > Secretary of AP2POP > > > > 2017-05-11 17:56 GMT+02:00 Emilie Henin <emilie.henin_at_gmail.com>: > >> Dear Colleagues, >> >> We are happy to announce the >> >> >> >> *2nd European Training Course on* >> *Pharmacokinetics and Pharmacodynamics of Protein Therapeutics – >> Principles and Pharmacometric Approaches * >> that will be held in Darmstadt, Germany on August 29-31, 2017. >> >> The 3-day course is a shortened version of the course which has been >> given for the last seven years by Prof Bernd Meibohm & Johan Gabrielsso n >> in the United States, and it is organized in EUROPE under the aegis of >> AP2POP and with the sponsoring of Merck. >> >> >> >> During this course, you will be introduced to basic principles in the >> pharmacokinetic and pharmacodynamic evaluation of novel therapeutic >> proteins and hands-on exercises in the PK/PD evaluation of these compoun ds. >> Topics include target-mediated drug disposition, tissue and tumor >> penetration, first-in-human dose selection, immunogenicity, clinical >> pharmacology challenges, biosimilars, and drug-drug interactions. The >> target audience comprises pharmaceutical scientists from industry, acade mia >> and regulatory agencies with basic knowledge in PK and PKPD that would l ike >> to receive a comprehensive overview or refresher on the PK and PKPD of t his >> class of compounds. Hands-on exercises will be performed individually an d >> in small groups using simple software tools (no prior experience require d). >> >> >> >> *Attendance and registration:* >> >> The attendance will be strictly limited to 35 participants, allowing nic e >> interactions. As well, a limited number of spots have been reserved for >> academia and trainees for one third of the price thanks to Merck >> sponsoring. >> >> >> >> For more detailed information on the preliminary course program, as well >> as on the registration process, please visit: >> >> *Information:* http://www.ap2pop.org/formations >> http://www.ap2pop.org/fr/Formations >> >> *Registration form:* http://www.ap2pop.org/assets/P >> DF/Plaquette-formation-AP2POP-2017-PKPDofPT.pdf >> >> >> >> >> Looking forward to seeing you in Darmstadt next summer ! >> >> >> *The Course Directors* >> Bernd Meibohm, University of Tennessee & Johan Gabrielsson, Swedish >> University of Agricultural Sciences >> >> >> >> *The Local Organizers* >> >> Pascal Girard and Maike Puetter, Merck; Christian Laveille, Calvagone >> > >